Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
GT Biopharma ( (GTBP) ) just unveiled an update.
On September 16, 2024, Dr. Jeffrey Miller transitioned from his dual role as Consulting Chief Medical Officer and Chief Scientific Officer to become the Consulting Senior Medical Director for the same company. This change aligns with the University of Minnesota’s conflict of interest policies, as Dr. Miller is employed by the university, which is poised to conduct a Phase I clinical trial of the company’s new GTB-3650 compound.
For a thorough assessment of GTBP stock, go to TipRanks’ Stock Analysis page.